Solid Lipid Nanoparticle–Loaded Acanthus ebracteatus Vahl. Extract for Androgenic Alopecia Treatment: A Randomized, Controlled, Open‐Label, Four‐Arm Parallel‐Group Clinical Study
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/5897441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 21.07.2026. Verfasst von Vanuchawan Wisuitiprot und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Center of Excellence for Life Sciences, Naresuan University, National Research Council of Thailand.
Abstract (Originalsprache)
Background
Androgenic alopecia (AGA) is a common type of hair loss, caused by the metabolism of testosterone into dihydrotestosterone and hair follicular microinflammation. Acanthus ebracteatus Vahl. (AE) extract has been reported as a promising anti‐hair loss agent. This article aims to clinically investigate the efficacy and safety of hair serum containing solid lipid nanoparticle–loaded AE in AGA volunteers.
Objective
The current study aimed to evaluate the efficacy of a hair serum containing SLN‐AE extract (SLN‐AE serum) and 5% minoxidil in the treatment of AGA.
Methods
Seventy‐two men with AGA were randomized to receive SLN‐AE serum, 5% minoxidil, a combination treatment (SLN‐AE serum + 5% minoxidil), or placebo, twice daily for 6 months. Clinical outcomes were assessed through hair count, global photographic review, hair shedding, and participant satisfaction with hair regrowth.
Results
The results revealed that SLN‐AE serum significantly improved hair regrowth, as evidenced by an increase in total hair count and the density of anagen hairs, as well as a significant decrease in the density of telogen hairs. The combination treatment also demonstrated effectiveness in increasing hair count at the earliest time.
Conclusion
The clinical outcomes indicate that AE extract is a promising candidate for AGA treatment due to its safety and effectiveness. Trial Registration: Thai Clinical Trial Registry: TCTR20240318001
Förderung
- Thailand Center of Excellence for Life Sciences
- Naresuan University
- National Research Council of Thailand
- Ministry of Higher Education, Science, Research and Innovation, Thailand
Zitieren
APA
Wisuitiprot, V., Chakkavittumrong, P., Ingkaninan, K., Wisuitiprot, W., & Waranuch, N. (2026). Solid Lipid Nanoparticle–Loaded Acanthus ebracteatus Vahl. Extract for Androgenic Alopecia Treatment: A Randomized, Controlled, Open‐Label, Four‐Arm Parallel‐Group Clinical Study. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/5897441
Vancouver
Wisuitiprot V, Chakkavittumrong P, Ingkaninan K, Wisuitiprot W, Waranuch N. Solid Lipid Nanoparticle–Loaded Acanthus ebracteatus Vahl. Extract for Androgenic Alopecia Treatment: A Randomized, Controlled, Open‐Label, Four‐Arm Parallel‐Group Clinical Study. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/5897441
BibTeX
@article{Wisuitiprot2026,
author = {Wisuitiprot, Vanuchawan and Chakkavittumrong, Panlop and Ingkaninan, Kornkanok and Wisuitiprot, Wudtichai and Waranuch, Neti},
title = {Solid Lipid Nanoparticle–Loaded Acanthus ebracteatus Vahl. Extract for Androgenic Alopecia Treatment: A Randomized, Controlled, Open‐Label, Four‐Arm Parallel‐Group Clinical Study},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/5897441}
}
EUVIMED